Cerebral amyloid angiopathy (CAA) is common in
Introduction
␤-amyloid (A␤) is a ubiquitous 4 kDa peptide that accumulates characteristically in the brain in Alzheimer's disease (AD) as parenchymal plaque deposits (Masters et al., 1985) and cerebral amyloid angiopathy (CAA) (Glenner and Wong, 1984) . CAA occurs in vessel walls of leptomeningeal (i.e., pia and arachnoid mater) and cerebral arterioles, arteries, and capillaries, is associated with smooth muscle cell degeneration, microinfarction, and hemorrhage (Coria et al., 1987; Kawai et al., 1992; Jellinger and Attems, 2003) , and may contribute more than plaque amyloid to cognitive loss (Pfeifer et al., 2002) .
CAA is not simply a product of bulk A␤ accumulation, because subregions of the brain (e.g., occipital lobe, thalamus) are especially vulnerable to CAA, whereas others (e.g., superior temporal cortex) are vulnerable to parenchymal A␤ deposition (Braak and Braak, 1996) . Some A␤ mutations cause profound CAA but minimal parenchymal amyloid deposition (Van Broeckhoven et al., 1990) .
These observations suggest that A␤ aggregation is triggered by reaction with microregional neurochemical factors, and two major promoters of A␤ deposition in amyloid ␤ protein precursor (APP) transgenic (Tg) mice are apolipoprotein E (ApoE) and Zn 2ϩ . Parenchymal amyloid and CAA are markedly inhibited by genetic ablation of mouse ApoE (Holtzman et al., 2000; Fryer et al., 2003) . ApoE, the isoforms of which modify the risk for AD, is expressed in brain and enriches within parenchymal amyloid and CAA (Fryer et al., 2003) . However, it is not yet clear how this protein behaves to foster A␤ deposition.
Zn 2ϩ also plays a major role in the reversible precipitation of A␤ (Bush et al., 1994b; Huang et al., 1997) . Zn 2ϩ is concentrated in amyloid plaques in AD and in Tg2576 mice (Lee et al., 1999; Suh et al., 2000) . Cu 2ϩ and Zn 2ϩ bind directly to A␤ subunits in brain plaque amyloid in AD through histidine bridges (Dong et al., 2003) , selectively copurify with A␤ from AD affected brain (Opazo et al., 2002) , and Cu 2ϩ /Zn 2ϩ chelation resolubilizes A␤ from postmortem AD tissue . Treatment of Tg2576 mice with the orally bioavailable Cu 2ϩ /Zn 2ϩ chelator clioquinol markedly decreases brain amyloid burden (Cherny et al., 2001 ).
Genetic ablation of the zinc transporter 3 (Znt3) is similar to ApoE ablation in inhibiting amyloid deposition in Tg mice (Lee et al., 2002) . ZnT3 inserts Zn 2ϩ in a chemically exchangeable form into synaptic vesicles and is only found in neocortical synaptic vesicles (Palmiter et al., 1996) . Zn 2ϩ [detected by N-(6-methoxy-8-quinolyl)-p-toluensulfonamide (TSQ)] is concentrated within CAA in AD (Suh et al., 2000) but unlike plaque amyloid, which accumulates in the vicinity of exchangeable Zn 2ϩ discharged into the synaptic space (Lee et al., 2002) , the origin of Zn 2ϩ within CAA is not obvious. Therefore, we investigated the effect of Znt3 gene ablation on cerebrovascular Zn 2ϩ levels in non-Tg mice and on CAA in Tg2576 mice to determine whether the activity of synaptic ZnT3 may affect A␤ deposition at a site remote from the synapse. Here, we report evidence that synaptic ZnT3 activity promotes CAA by indirectly raising exchangeable Zn 2ϩ levels in the perivascular spaces of cerebral and leptomeningeal vessel walls. (Palmiter and Huang, 2003) . Genotyping was performed as described previously (Hsiao et al., 1995; Cole et al., 1999) . All animal experiments were performed in accordance with the National Institutes of Health guideline for welfare and use of laboratory animals.
Materials and Methods
Histochemistry and immunocytochemistry. At 15 months of age (n ϭ 7 for APP ϩ /Znt3 ϩ/ϩ ; n ϭ 7 for APP ϩ /Znt3 ϩ/Ϫ ; n ϭ 7 for APP ϩ / Znt3 Ϫ/Ϫ ) or 18 months of age (n ϭ 8 for APP ϩ /Znt3 ϩ/ϩ ; n ϭ 7 for APP ϩ /Znt3 ϩ/Ϫ ; n ϭ 7 for APP ϩ /Znt3 Ϫ/Ϫ ), coronal brain sections (bregma plus 3.0 mm) were processed for Congo Red histochemistry and anti-A␤ immunocytochemistry.
For Congo Red staining, 10 m thick sections were first stained in Gill's hematoxylin solution (Sigma, St. Louis) for 10 min and then rinsed in tap water for 5 min and incubated in alkaline sodium chloride solution for 20 min. Sections were then stained with alkaline Congo Red solution (0.2% in 80% ethanol saturated with sodium chloride; Sigma) and washed in absolute ethanol (Lee et al., 1999) .
For A␤ immunocytochemistry, 10 m thick sections were treated with 3% hydrogen peroxide in methanol for 30 min. After blocking with 1% bovine serum albumin (BSA) and 3% goat serum in PBS, the sections were incubated for 24 hr at 4°C with the primary antibody (Ab) (antihuman amyloid ␤ Ab; PharMingen, San Diego, CA; 1:500) in PBS containing 1% BSA and 3% goat serum. The sections were sequentially incubated with biotinylated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA), avidin-horseradish peroxide solution (Vector Laboratories), 0.015% diaminobenzidine plus 0.001% hydrogen peroxide (Vector Laboratories), and finally counterstained with hematoxylin. For anti-ZnT3 immunostaining, the sections were reacted with affinitypurified ZnT-3 Ab (1:50) as described previously (Palmiter et al., 1996) .
The identification and quantification of exchangeable Zn 2ϩ in cerebral and peripheral blood vessels (Fig. 6, Table 2 ) was performed by a blinded observer. Tissue samples were handled uniformly and systematically, as in our previous studies using TSQ and N-(6-methoxy-8-quinolyl)-p-carboxybenzoylsulphonamide (TFL-Zn) to monitor fluorescence in the brains of Tg2576 mice (Lee et al., 1999 (Lee et al., , 2002 . Immediately after cryostat preparation, unfixed frozen brain sections (12 m) were incubated for 90 sec with 0.25 mM TFL-Zn (Budde et al., 1997) (Tef Labs, Austin, TX) dissolved in Tris-Cl buffer (0.1 mM, pH 8.0). Immediately after washing in 0.9% NaCl solution, pH 7.2, for 15 sec, the sections were photographed with a digital camera (Camedia Z-2000; Olympus Optical, Tokyo, Japan) under a fluorescence microscope (BX60; Olympus Optical) using a U-MWU cube, dichroic mirror (400 nm), excitation filter (330 -385 nm), and barrier filter (420 nm). The barrier filter used (BA420) has a steep exclusion slope for wavelengths of light Ͻ420 nm but permits transmission of wavelengths Ͼ420 nm. Therefore, the excitation-barrier filter combinations that we used were suitable for the evaluation of TFL-Zn fluorescence, which has excitation and emission peaks of 360 and 498 nm, respectively (Budde et al., 1997) .
After the conversion of the fluorescent images into a black and white mode, the fluorescence intensity in vessel walls was determined with a computer-assisted image analysis program (Image-Pro; Media Cybernetics, Silver Spring, MD). The vessel walls were traced, and fluorescence was quantified within the trace lines. Because of inaccuracies in tracing small vessels with this technique, only larger vessels (30 -100 m) were traced. To control for vessel wall autofluorescence, intensities from unstained sections were quantified as described above and determined to not contribute to Ͼ5% of assayed fluorescence in all organs and did not differ between the two groups. For each organ in each mouse, the average fluorescence intensity measured from 10 blood vessels (with major axis; 30 -100 m) on one tissue section was calculated. The average intensity per group was then determined (n ϭ 7 for Znt3 ϩ/ϩ ; n ϭ 6 for Znt3 Ϫ/Ϫ ), and the value of TFL-Zn fluorescence was normalized to the mean fluorescence in Znt3 ϩ/ϩ mice (100%). Timm's stain. Protocols were as published previously (Danscher and Zimmer, 1978; Danscher, 1981; Perez-Clausell and Danscher, 1985) . Mice were transcardiac perfused under deep anesthesia with buffered sodium sulfide solution (12 gm/l Na 2 S.H 2 O, 12 gm/l NaH 2 PO 4 .H 2 O, pH 7.4) (1 min), 4% paraformaldehyde solution (10 min), and then buffered sodium sulfide solution (10 min). For Neo-Timm's (Holm, 1989) , DBA mice were administered 20 mg/kg Na 2 SeO 3 (2 mg/ml in normal saline) by intraperitoneal injection 2 hr before perfusion. Paraffin sections were mounted on gelatinized slides and dried. The slides were rehydrated (96% alcohol for 15 min, 70% alcohol for 2 min, 50% alcohol for 2 min, and then 3 dH 2 O) for 3 min. The slides were placed in developing solution in the water bath at 26°C in the dark for 60 min. Developing solution is made by mixing 60 ml of gum Arabic solution (500 gm/l) with 10 ml of citrate buffer (255 Western blotting. From mouse, blood was collected from 12-month-old female mice from the inferior vena cava into a heparinized syringe. Platelets, erythrocytes, and plasma were separated as described previously (Bush et al., 1990) . Cell pellets or solid tissue were homogenized in eight volumes of sample buffer (2% SDS/5% 2-mercaptoethanol/50 mM Tris-HCl, pH 7.0) and boiled. Western blotting was performed as described previously (Goldstein et al., 2003) , except 1:500 antiZnT3 primary Ab was used.
Inductively coupled plasma mass spectroscopy. Blood was collected from 12-month-old female mice from the inferior vena cava into an EDTAtreated syringe and transferred into plastic tubes prewashed with 1% HNO 3 . HNO 3 was inductively coupled plasma mass spectroscopy (ICPMS) grade "Aristar" (BDH Chemicals, Poole, UK). Plasma was immediately separated and later analyzed by ICPMS using an Ultramass 700 (Varian, Victoria, Australia) in peakhopping mode with one point per peak, 50 scans per replicate, and three replicates per sample. Plasma flow was 15 L/min with auxiliary flow of 1.5 L/min. Radio frequency power was 1.2 kW. Samples were introduced using a glass nebulizer at a flow rate of 0.88 L/min. The apparatus was calibrated using a 1% HNO 3 solution containing Cu and Zn at 5, 10, 50, and 100 ppb, with 89Y as the internal standard for all isotopes of Cu and Zn. Statistical analysis. Differences between groups were assessed by individual analysis of difference in the means as unpaired t tests with unequal variance. A p value of Ͻ0.05 was considered significant.
Results
Genetic ablation of Znt3 markedly decreased CAA in the brains of Tg2576 mice (Figs. 1, 2, 3 ). In parallel with reduced interstitial A␤ deposition, the numbers of Congo Red birefringent and anti-A␤-immunopositive vessels in the neocortex were markedly and significantly reduced in the APP ϩ /Znt3 ϩ/Ϫ and APP ϩ /Znt3 Ϫ/Ϫ mice at both 15 and 18 months of age (Figs. 1, 3 ). In agreement with previous reports (Cole et al., 1999) , histochemically reactive Zn 2ϩ (which is contained in vesicles) in the hippocampal mossy fibers was decreased by ZnT3 genetic ablation (Fig. 4 A-D) . We also noted that TFL-Zn fluorescence was frequently detected in the perivascular space of small and medium sized neocortical, thalamic, and leptomeningeal vessels in wild-type mice and was significantly diminished by Ϸ20% in Znt3-deficient mice (Fig.  4 E-L; Table 2 ). These results imply that, somehow, CAA formation is linked to a pool of Zn 2ϩ that communicates between the synaptic boutons and the cerebrovascular wall.
To confirm the presence of such a pool, we performed Timm's stains on normal mice and examined brain areas that are most prone to CAA deposition (pial, thalamic, cortical, and hippocampal vessels) (Preston et al., 2003) . Neocortical neuropil stains so darkly with the Timm's stain (because of zinc in synaptic vesicles) (Danscher, 1981; Holm et al., 1987 ) that the vessel walls were hard to differentiate in the neocortex and on the pial surface. However, we visualized distinct cerebral vessel wall staining by Timm's stain in hippocampal and thalamic areas (where there are regions of little background, because the synaptic boutons do not contain exchangeable Zn 2ϩ ) (Fig. 5 ). Timm's staining revealed numerous casts of small vessels with puncta that could represent endothelial cell nuclei (Danscher, 1981) or possibly astrocytic foot processes (Fig. 5 B, D) . The intravital trapping of free zinc by the Timm's procedure excludes the possibility that the vessel wall zinc detected is because of artifactual release by slicing.
Although CAA and parenchymal amyloid are both much less abundant in Tg2576 after Znt3 gene ablation, the amount of CAA in APP ϩ /Znt3 Ϫ/Ϫ mice still increased between 15 and 18 months of age (Figs. 1, 3) . We hypothesized that Zn 2ϩ from sources other than ZnT3 activity could contribute to this residual amyloid accumulation. We determined that residual CAA and interstitial amyloid that is deposited by 18 months of age in APP ϩ /Znt3 Ϫ/Ϫ mice still contains an enrichment of histochemically reactive zinc, qualitatively similar to that of APP ϩ /Znt3 ϩ/ϩ mice (Fig. 6 ). This suggests that some of the Zn 2ϩ that induces CAA and plaque formation can originate from sources other than the synapse, but that most of the Zn 2ϩ for CAA pathogenesis is ZnT3 dependent. We next determined whether the vessel wall could receive Zn 2ϩ from ZnT3 expression in other tissue components. Previous studies have localized ZnT3 solely to presynaptic vesicle membranes (Palmiter et al., 1996; Wenzel et al., 1997; Cole et al., 1999; Kay, 2003) , and ZnT3 mRNA and protein are known not to be present in cortical vessels (Palmiter et al., 1996) . We confirmed the absence of ZnT3 immunoreactivity in cerebral blood vessels of wild-type mice (Fig. 4G ) and excluded the presence of ZnT3 in major blood components (platelets, erythrocytes, and plasma) by Western blot (Fig. 4 M) . Therefore, the ZnT3-mediated pool of exchangeable Zn 2ϩ detected in cerebral vessel walls appears to be derived solely from synaptic ZnT3 activity.
We examined bulk metal levels in organs of Znt3 knock-out mice and their wild-type littermates ( cerebral cortex but not different in cerebellum, kidney, heart, or pancreas of Znt3 Ϫ/Ϫ mice compared with Znt3 ϩ/ϩ littermates. Liver zinc levels were elevated by 12.4% in Znt3 Ϫ/Ϫ mice near the margin of statistical significance. Tissue Cu levels were unaffected by Znt3 knock-out.
In peripheral organs that do not express ZnT3, including heart, liver, and kidney, histochemically reactive zinc was also detected in the perivascular space but was not decreased in Znt3 knock-out animals (Fig. 7, Table 2 ). Therefore, perivascular dissociable Zn 2ϩ in the neocortex is a physiologically unique pool with a significant proportion of its concentration (Table 2) dependent on Zn 2ϩ transport at the remote synapse.
Discussion
We demonstrated that CAA is markedly decreased after targeted disruption of the Znt3 gene. This may be explained by a remote effect of ZnT3 activity located in synaptic vesicles in raising exchangeable perivascular Zn 2ϩ concentrations in the brain neocortex (Fig. 4, Table 2 ). Exchangeable Zn 2ϩ was also identified by Timm's stain in vessel walls of the hippocampus and thalamus (Fig. 5) . These findings are consistent with the sites of CAA formation in APP transgenic mice (CAA in the thalamus and parts of the hippocampus is known to form at a distance from the sites of plaque deposition), even when neuronal-specific expression of A␤ occurs (i.e., no vascular origin of A␤) (Calhoun et al., 1999) .
Most tissue Zn 2ϩ is tightly held in proteins like metallothionein and transcription factors and not readily available for chemical exchange with the exterior (Frederickson and Bush, 2001) . Synaptic vesicular Zn 2ϩ is far more loosely ligated and exteriorizes during synaptic transmission, where Zn total concentration has been reported to rise to 300 M (Howell et al., 1984) , although only a small fraction of this may be freely ionic (Kay, 2003 Table 2 for quantifications. 1981) and various fluorescent dyes (e.g., TSQ and TFL-Zn) (Budde et al., 1997; Frederickson and Bush, 2001 ). The Zn 2ϩ fluorophores TSQ and TFL-Zn strongly detect Zn 2ϩ in amyloid plaques in Tg2576 mice and in AD cases (Lee et al., 1999 (Lee et al., , 2002 (Lee et al., , 2004 Suh et al., 2000; Bush, 2003) . The Zn 2ϩ binding sites on A␤ have affinity constants of Ϸ100 nM to Ϸ10 M (Bush et al., 1994a) ; affinities that are low enough to surrender Zn 2ϩ for TSQ and TFL-Zn to either make ternary A␤-Zn-dye complexes or release Zn-dye complexes that embed in the pathology on the basis of lipophilicity (Snitsarev et al., 2001) . The detection of Zn 2ϩ in vessel walls by TFL-Zn (Fig. 4 ) and Timm's (Fig. 5) stains implies that this Zn 2ϩ is in the proximity of perivascular space contents.
The neocortical perivascular spaces may function as an efflux or drainage system joining the brain interstitial spaces to the capillary walls and then larger arteries, arterioles, and leptomeningeal vessels. The efflux of A␤ from the brain to peripheral circulation may be mediated by this route (Weller et al., 1998; Preston et al., 2003) . Our data indicate that neuronal Zn 2ϩ may also communicate with the periphery through this route. Therefore, CAA may be promoted by neuronal Zn 2ϩ that is externalized by synaptic transmission, abnormally reacting with A␤ that is exiting the brain. This may explain why the synaptic cleft and the neocortical perivascular spaces (Yamaguchi et al., 1992) are the two most likely sites of A␤ deposition, because they are the sites with the highest fluxes of exchangeable Zn 2ϩ in the brain. ApoE is also essential for CAA formation in the perivascular spaces of the cerebral vessels in APP transgenic mice (Holtzman et al., 2000; Fryer et al., 2003) . ApoE binds transition metal ions, including Zn 2ϩ (Miyata and Smith, 1996) . We previously found that the ability of ApoE to buffer Zn 2ϩ protects A␤ from precipitation by Zn 2ϩ , and that the E4 isoform is the worst Zn 2ϩ buffer (ϽE3 ϽE2) (Moir et al., 1999) , paralleling the association of the ApoE isoform with the risk for AD. Because ApoE may colocalize with exchangeable Zn 2ϩ in the perivascular space of cerebral vessels, we hypothesize that A␤ may be precipitated at this site by Zn 2ϩ , which is in exchange with ApoE. One hypothesis that may unify the findings is that ApoE may normally ferry some Zn 2ϩ from the liver (where ApoE is synthesized) to neocortical ZnT3 and therefore, in ZnT3 knock-out mice, liver Zn 2ϩ levels rise (and plasma zinc levels fall) ( (Fig. 6) , as well as the presence (albeit attenuated) of Zn 2ϩ in the cerebrovascular walls of Znt3 Ϫ/Ϫ mice (Fig. 4 L) , suggests that components of the vessel walls themselves could also offer exchangeable Zn 2ϩ . The small but significant decrease in cerebral bulk Zn levels induced by ZnT3 ablation (Ϸ13%) (Table 1) confirms our previous results in younger mice (6 -12 months of age) (Lee et al., 2002 (Lee et al., , 2004 and is consistent with previous estimates of the contribution of synaptic bouton zinc to total brain zinc content (Holm et al., 1987; Frederickson et al., 1992) . The marked diminution in congophilic angiopathy in APP ϩ /Znt3 Ϫ/Ϫ mice ( Fig.  3 A, C) appears disproportionately greater than the Ϸ20% loss in Zn 2ϩ fluorescence measured in the neocortical vessel walls of nontransgenic mice (Table 2 ). This may be explained by a degree of unavoidable loss of some extracellular Zn 2ϩ during histological preparation, decreasing our estimation of the differences in Zn 2ϩ concentration in the vessel walls. Also, the TFL-Zn and TSQ fluorescent dyes may only be semiquantitative indicators of Zn 2ϩ concentration, because the lipid environment of the neuronal membranes may make the relationship between Zn 2ϩ binding to the TFL-Zn indicator nonlinear (Snitsarev et al., 2001) . Therefore, although the decrease in TFL-Zn fluorescence in ZnT3 knock-out mice indicates that a significant decrease in detectable Zn 2ϩ has occurred as a result of the ZnT3 genetic ablation, this decrease may be Ͼ20% in absolute value.
There is evidence for increased soluble A␤ concentrations in both AD and APP-transgenic brain tissue (Lue et al., 1999; McLean et al., 1999) . We proposed that Alzheimer amyloid formation is the product of an abnormal elevation of soluble A␤, perhaps liberated from its normal membrane-associated cellular compartment by an abnormal oxidation (Barnham et al., 2003) , that then drifts into microanatomical regions (synapse and perivascular space) possessing exceptionally high Zn 2ϩ concentrations that induce A␤ precipitation (Bush, 2003) . Once the A␤ accumulates, however, it may impede the flow of A␤ and Zn 2ϩ through the perivasculature. ZnT3 activity contributes to a flux of brain Zn 2ϩ that is likely to subserve important physiologic functions and contributes ϳ14% of plasma Zn levels in mice (Table  1 ). Therefore, it is possible that the trapping of essential Zn 2ϩ in the amyloid mass in AD may contribute to central and peripheral Zn 2ϩ deficiency. A recent phase 2 clinical trial of the Cu 2ϩ and Zn 2ϩ chelator clioquinol induced a significant Ϸ25% increase in plasma Zn 2ϩ levels in AD subjects over a 9 month treatment regimen (Ritchie et al., 2003) . On the basis of our current findings, this increase in plasma Zn 2ϩ may be attributable to the dissolution of CAA, leading to increased Zn 2ϩ flux between the pool of brain synaptic Zn 2ϩ and the peripheral circulation. Our findings of decreased CAA in Tg2576 mice after Znt3 gene ablation suggest that the pathways involved in ZnT3-dependent zinc transport may have therapeutic relevance in AD.
